Navigation Links
Zolpidem in Medical News

Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia

WESTCHESTER, Ill. A study published in the January 1 issue of the journal SLEEP finds that zolpidem extended-release 12.5 mg, taken three to seven nights per week for up to six months, provided sustained and significant improvements in sleep onset and maintenance, and also improved next-day conce...

Transcept Pharmaceuticals to Report Second Quarter 2009 Results

...-based sleep aids, in a formulation designed to promote rapid sublingual absorption. Transcept believes that Intermezzo (R), by combining the reduced zolpidem dose with administration only on those nights when a middle of the night awakening actually occurs, has the potential to reduce unnecessary sedative-h...

Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009

...d there were no significant residual effects upon awakening four hours after dosing. Transcept believes that Intermezzo (R), by combining the reduced zolpidem dose with administration only on those nights when a middle of the night awakening actually occurs, has the potential to reduce unnecessary sedative-h...

Odd Behaviors on Ambien Linked to Brain Circuitry

...ity Medical Center in Washington, D.C., found that zolpidem shuts down some powerful brain circuits but activa...'asleep'," she explained. While it appears that zolpidem shuts down active neural pathways and perhaps trig... More information MedlinePlus has more about zolpidem . -- Robert Preidt ...

Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association

... Safety and Efficacy Study of zolpidem Tartrate Sublingual Tablet in Treating Middle-of-t...alifornia. The first poster, titled "Low-Dose zolpidem Tartrate Sublingual Tablet Safely and Effectively ... was to evaluate the safety and efficacy of 3.5 mg zolpidem tartrate sublingual tablet (ZST) when taken on an ...

Pills Plus Psychotherapy Can Beat Insomnia

...l Association , found that the short-term addition of the sleep medication, zolpidem (Ambien), coupled with cognitive behavioral therapy, helped more people ove...atients good sleep habits. Another approach is sleep medications -- such as zolpidem (Ambien), eszopiclone (Lunesta) and zaleplon (Sonata). These are the onl...

Large users of zopiclone assessed as impaired

...medicines Hypnotics that contain zopiclone and zolpidem (e.g. Imovane and Stilnoct) are widely used throug...s a link between the concentration of zopiclone or zolpidem in the blood and being assessed as impaired during...opiclone. Abuse potential - Zopiclone and zolpidem are usually used in moderate amounts before bedtim...

Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.

...tic needs in the fields of psychiatry and sleep medicine. The lead Transcept product candidate, Intermezzo(R), is a sublingual low dose formulation of zolpidem that has been developed for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sl...

Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel

...tic needs in the fields of psychiatry and sleep medicine. The lead Transcept product candidate, Intermezzo(R), is a sublingual low dose formulation of zolpidem that has been developed for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sl...

Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference

...tic needs in the fields of psychiatry and sleep medicine. The lead Transcept product candidate, Intermezzo(R), is a sublingual low dose formulation of zolpidem that has been developed for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sl...
Zolpidem in Medical Technology

Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings

...is a low dose, buffered, sublingual formulation of zolpidem intended to be the first prescription sleep aid to...dose. Transcept believes that these are the lowest zolpidem doses that have been reported to be statistically ...time remaining in bed. The rapidly absorbed, lower zolpidem dose used in Intermezzo(R) has been developed to t...

Prescription Sleeping Pill Use Tied to Cancer

...he carcinogenic effects of drugs. The effects of 556 person-years of taking either zaleplon (Sonata), Eszopiclone (Lunesta), ramelteon (Rozerem) and zolpidem (Ambien) were assessed, compared to a control group who took a placebo over 230 person-years. Kripke found eight non-melanoma skin cancers and four tu...

Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose

...duced by a swallowed Ambien(R) tablet containing a zolpidem dose that was nearly 3 times higher. Despite this higher initial bioavailability, zolpidem blood levels from sublingual 3.5 mg Intermezzo(R) ...p onset vs. placebo; these are the lowest doses of zolpidem ever shown to be statistically effective vs. place...

Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008

...sful completion of a second Phase 3 clinical trial of Intermezzo(R) (3.5 mg zolpidem tartrate sublingual lozenge), a low dose buffered sublingual formulation de...te, Intermezzo(R) (zolpidem tartrate lozenge), is a low dose formulation of zolpidem for the treatment of insomnia in patients who awaken in the middle of the n...

Neurogen Proprietary Insomnia Compound Data Presented at American Psychiatric Association Annual Meeting

... study where 19 subjects received single oral doses (1, 3, 5, 10 mg NG2-73, zolpidem 10 mg (Z10), and placebo), compared ER between NG2-73 doses and zolpidem. P...-maximal visual analog scale effects were approximately 13-fold greater for zolpidem vs. NG2-73. Maximal concentration (Cmax) for NG2-73 10 mg was approximately...

New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon

...as in previous studies, that patients treated with zolpidem did have impaired performances on these measures, ...eek for over three months received ramelteon 8 mg, zolpidem 10 mg or placebo 30 minutes before bedtime for one... decrease in SOT composite score was observed with zolpidem (P<0.001), but not with ramelteon (P=0.837). Addit...

NovaDel Announces Positive Data from Two Studies Comparing Zolpidem Oral Spray to Ambien Tablets

...linical studies comparing zolpidem oral spray with zolpidem tablets have met their primary pharmacokinetic (PK... from NovaDel's earlier pilot PK and PD studies of zolpidem oral spray and support the Company's objective to submit a new drug application (NDA) this year for zolpidem oral spray using the FDA's 505(b)(2) regulatory pr...

Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia

...rmance in older adults with chronic insomnia, with zolpidem as a positive control. A total of 33 adults age 65...older with chronic insomnia received ROZEREM 8 mg, zolpidem 10 mg or placebo 30 minutes before bedtime for one...e in mean SOT composite score was observed between zolpidem and placebo (P<0.001), but not between ROZEREM and...

Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting

...l have an improved side effect profile compared to zolpidem based on ethanol interaction and on assessments of... (PD) of NG2-73 at doses of 1, 3, 5, and 10 mg and zolpidem 10 mg versus placebo in healthy subjects. This w...e seen with the EBFB, DSST, PVT and posturography. zolpidem 10 mg had effects that appeared similar to a dose ...
Zolpidem in Biological News

Insomnia drug can improve brain function

...Two years after the suicide attempt, she was given zolpidem for a bout of insomnia; 20 minutes later, she was ... researchers systematically assessed the effect of zolpidem on motor and cognitive function and explored its e...g PET scans. All of these were conducted with both zolpidem and a placebo in a randomized, double-blind study....
Zolpidem in Biological Technology

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...ased sleep aids, in a formulation designed to promote rapid sublingual absorption. Transcept believes that Intermezzo ((R)), by combining the reduced zolpidem dose with administration only on those nights when a middle of the night awakening actually occurs, has the potential to reduce unnecessary sedative-h...

Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)

...is a low dose, buffered, sublingual formulation of zolpidem intended to be the first prescription sleep aid in...ion. Transcept believes that these are the lowest zolpidem doses that have been reported to be statistically ...zzo (R) , is a sublingual low dose formulation of zolpidem that has been developed for use as-needed for the ...

Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP

...Societies. Intermezzo(R) is a low dose, buffered, sublingual formulation of zolpidem intended to be the first prescription sleep aid to be indicated for use as-...t product candidate, Intermezzo(R), is a sublingual low dose formulation of zolpidem that has been developed for use as-needed for the treatment of insomnia whe...

Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference

...tic needs in the fields of psychiatry and sleep medicine. The lead Transcept product candidate, Intermezzo(R), is a sublingual low dose formulation of zolpidem that has been developed for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sl...

Transcept Pharmaceuticals Appoints Key Senior Executives

...cal benefits for existing active agents. The lead Transcept product candidate, Intermezzo(R) (zolpidem tartrate lozenge), is a low dose formulation of zolpidem for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty returning to sleep. Phase 3 clinical trials have b...

Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel

...l benefits for existing active agents. The lead Transcept product, Intermezzo(TM) (zolpidem tartrate lozenge), is a low dose sublingual formulation of zolpidem that is currently in late phase 3 clinical trials for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty ...
Other Tags
(Date:1/22/2015)... 2015 Joan Lunden, award-winning American journalist, ... the upcoming 32nd Annual Miami Breast Cancer Conference ... Resource®, LLC (PER®) , shares that “a fast-growing, virulent” ... if she had not followed up her clean mammogram ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and easy ... treat specific body parts and muscle groups. , IsoComforter, ... use patented cold therapy machine with the innovative IsoTube design ... injuries. IsoComforter has become the industry leader in cold ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... 22, 2015 As interest in the value ... gains momentum worldwide, Rev. Eric J. Hall , president ... (HCCN), will be the keynote speaker on January 27 ... public health system. , The conference, “Hope and Resilience: Innovative ...
Breaking Medicine News(10 mins):Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
(Date:1/22/2015)... January 22, 2015 , ... The European Patent Office to present a video retrospective ... nominations to be featured: Christofer Toumazou and Sophie ... finalists and winners of the Award   Starting on ...
(Date:1/22/2015)...   EyeLock, Inc. , a market leader of iris-based identity ... to the new role of Senior Vice President of ... of mobile platforms and wearable solutions for EyeLock,s technologies. Gerber ... the semiconductor industry to his role at EyeLock, with expertise ...
(Date:12/24/2014)... launch in December 2014, the 1U™ app has ... to remember their usernames and passwords through replacing the antiquated ... assist people who have struggled to remember usernames and passwords, ... focuses on redefining identity, announced today that it is offering ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3
Other Contents